Answers are grounded in this paper and cite their sources.
Develops a precision medicine pipeline for ovarian cancer, suggesting targeted therapies through multi-omics integration.
Ovarian cancer is a highly heterogeneous disease where traditional histological classification often fails to reflect underlying molecular diversity. We aimed to develop a precision medicine pipeline by comparing advanced multi-omics integration frameworks to identify robust molecular subtypes and prioritize subtype-specific therapeutic targets through in silico validation.
No takes yet. Share an insight, caveat, or question.
Coskun et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: